The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Apr. 16, 2019
Filed:
May. 10, 2017
Genentech, Inc., South San Francisco, CA (US);
Constellation Pharmaceuticals, Inc., Cambridge, MA (US);
Brian K. Albrecht, Cambridge, MA (US);
Steven F. Bellon, Cambridge, MA (US);
Daniel J. Burdick, South San Francisco, CA (US);
Alexandre Cote, Cambridge, MA (US);
Terry Crawford, South San Francisco, CA (US);
Les A. Dakin, Cambridge, MA (US);
Vickie Hsiao-Wei Tsui, South San Francisco, CA (US);
Michael Charles Hewitt, Cambridge, MA (US);
Yves LeBlanc, Cambridge, MA (US);
Steven R. Magnuson, South San Francisco, CA (US);
Christopher G. Nasveschuk, Cambridge, MA (US);
F. Anthony Romero, South San Francisco, CA (US);
Yong Tang, Cambridge, MA (US);
Alexander M. Taylor, Cambridge, MA (US);
Shumei Wang, South San Francisco, CA (US);
GENENTECH, INC., South San Francisco, CA (US);
CONSTELLATION PHARMACEUTICALS, INC., Cambridge, MA (US);
Abstract
The present invention relates to compounds of formula (I): and to salts thereof, wherein R, R, R, and Rhave any of the values defined in the specification, and compositions and uses thereof. The compounds are useful as inhibitors of bromodomains. Also included are pharmaceutical compositions comprising a compound of formula (I) or a pharmaceutically acceptable salt thereof, and methods of using such compounds and salts in the treatment of various bromodomain-mediated disorders.